Heimo Lagler
Medical University of Vienna
87 Papers
334 Citations
Heimo Lagler is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 20, co-authored 73 publications. Previous affiliations of Heimo Lagler include Vienna General Hospital & Semmelweis University.
Chat about Author
Papers
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.
Selma Tobudic,Christina Forstner,Heinz Burgmann,Heimo Lagler,Michael Ramharter,Michael Ramharter,Christoph Steininger,Matthias G. Vossen,Stefan Winkler,Florian Thalhammer +9 more
TL;DR: The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively and the clinical success rate was high, but in 24 of 27 patients dalBavancIn was used only after clearance of bacteria from the bloodstream.
TREM-1 Activation Alters the Dynamics of Pulmonary IRAK-M Expression In Vivo and Improves Host Defense during Pneumococcal Pneumonia
Heimo Lagler,Omar Sharif,Isabella Haslinger,Ulrich Matt,Karin Stich,Tanja Furtner,Bianca Doninger,Katharina Schmid,Rainer Gattringer,Alex F. de Vos,Sylvia Knapp +10 more
TL;DR: The data show that TREM-1 exerts a protective role in the innate immune response to a common bacterial infection and suggest that caution should be exerted in modulating T REM-1 activity during certain clinically relevant bacterial infections.
D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study.
Michael Schwameis,Margarete Steiner,Christian Schoergenhofer,Heimo Lagler,Nina Buchtele,Petra Jilma-Stohlawetz,Thomas Boehm,Bernd Jilma +7 more
TL;DR: The findings suggest that D-dimer, but not plasma histamine, could be a promising marker of lethality already at a very early stage of blood stream infection.
65
Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.
Rainer Gattringer,Heimo Lagler,Klaus-Bernhard Gattringer,Sylvia Knapp,Heinz Burgmann,Stefan Winkler,Wolfgang Graninger,Florian Thalhammer +7 more
TL;DR: Two case studies of patients treated with anakinra, an interleukin-1 (Il-1) receptor antagonist, with recurrent FMF attacks associated with severe abdominal pain and fever are presented.
65
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.
Manuel Kussmann,Matthias Karer,Markus Obermueller,Katy Schmidt,Wolfgang Barousch,Doris Moser,Marion Nehr,Michael Ramharter,Michael Ramharter,Wolfgang Poeppl,Athanasios Makristathis,Stefan Winkler,Florian Thalhammer,Heinz Burgmann,Heimo Lagler +14 more
TL;DR: For the first time, in vivo induced dalbavancin non-susceptible/teicoplanin resistant, but vancomycin and daptomycin susceptible S. aureus SCVs are demonstrated, indicating the emergence of a novel lipoglycopeptide resistance mechanism.
59